Lay Summary
VAP-1 in PSC: latest findings published
New and exciting findings about the activity of the enzyme, VAP-1.
Read MoreTreatments for PSC and PBC
Update on pharmacotherapies (treatemnts) for cholestatic liver disease.
Read MoreFactors affecting clinical course of PSC
Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associated With Course of Primary Sclerosing Cholangitis.
Read MoreUpdate on the genetics of PSC
New discoveries from an international PSC genetic study open the door to new potential drug targets and trials.
Read MorePSC Support Presents Patient Perspective to Regulatory and Research Authorities
Accelerating PSC research and raising the bar.
Read MoreA Holistic Approach to Liver Health: Our Voice is Heard
Chief Medical Officer acknowledges multiple causes of liver disease and need to reduce stigma.
Read MoreCall for a Holistic Approach in Addressing Burden of Liver Disease
PSC Support writes to Chief Medical Officer.
Read More